Generous German funding helps Ribozyme

Article Abstract:

Ribozyme Pharmaceuticals has started a new company, Atugen Bitoechnology. The new company, which is located in Berlin, will take on Ribozyme's target discovery and validation business. Atugen will have about $30 million in capitalization and $10 million more from the German and Berlin governments in 2001 and 2002. Michael Steinmetz, managing director at MPM Asset Management, believes that Atugen will be profitable within three years.

Germany, Organizational history, Parent-to-subsidiary activities, Article, Sirna Therapeutics Inc., Atugen Biotechnology GmbH

---

Can bioremediation bounce back? As the market for bioremediation using genetically modified microorganisms is eroded by controversy over the technology, transgenic plants may take center stage for environmental cleanup

Article Abstract:

Bioremediation offers the possibility of quicker, safer, and cheaper methods for cleaning up toxic chemicals in situ or ex situ than currently is being used globally. Yet, resistance exists against natural and genetically-modified microorganisms, which could shift clean up to genetically-modified plants.

Plant Genetics, Refuse systems, Hazardous Waste Treatmnt,Storge,Disposl, Hazardous Waste Collection, Pollutants produced & recycled, Hazardous waste management

---

Market woes drag down biotech shares

Article Abstract:

This article discusses the status of biotechnology stocks in the aftermath of the September 11 terrorist attacks. Biotechnolgy stocks followed the generally bearish selling atmosphere throughout the world.

Stocks & Other Equity Securities, Statistical Data Included, Brief Article

Similar abstracts:

• Abstracts: International developments: Tokyo. A note on market efficiency, institutional practice, and economic constraints in the experience of the Canadian bond market
• Abstracts: Patent pools and standard setting in diagnostic genetics. The global stem cell patent landscape: Implications for efficient technology transfer and commercial development
• Abstracts: Greasy money. Tools for trade: Canada's success as a leading exporter is opening up new opportunities for financing this country's foreign trade
• Abstracts: Informed trading and order type. Information precision, transaction costs, and trading volume. Insider trading and managerial incentives
• Abstracts: Trading mechanisms and trading preferences on a 24-hour futures market: a case study of the Floor/GLOBEX switch on MATIF

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.